Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCD in Invasive Candidiasis and Invasive Aspergillosis
NCT05707832Phase 3Completed
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Mar 2023
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b cholesteryl sulfate complex in invasive candidiasis, invasive aspergillosis (IA), sponsored by CSPC Ouyi Pharmaceutical. Started Mar 2023; status: completed.
02
Drugs
amphotericin b cholesteryl sulfate complex
03
Conditions
invasive candidiasisinvasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT05707832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707832.